SOLS — Solstice Advanced Materials Inc.
NASDAQ
Q3 2025 Earnings Call Summary
November 6, 2025
Summary of Solstice Advanced Materials Q3 2025 Earnings Call
1. Key Financial Results and Metrics
- Net Sales: $969 million, up 7% year-over-year.
- Adjusted Stand-alone EBITDA: $235 million, a 5% decrease year-over-year, with an EBITDA margin of 24.3%.
- Net Loss: $35 million attributed to Solstice, primarily due to higher income tax expenses related to the spin-off.
- Organic Net Sales Growth: 5%, driven by 2% volume growth and 3% pricing.
- Segment Performance:
- Refrigerants & Applied Solutions: $687 million in net sales (9% growth), with a 35.4% adjusted EBITDA margin.
- Electronic and Specialty Materials: $282 million in net sales (2% growth), with a 16.7% adjusted EBITDA margin.
2. Strategic Updates and Business Highlights
- Successful spin-off from Honeywell on October 30, 2025, with Solstice now listed on Nasdaq under the ticker SOLS.
- Continued strong demand in the Refrigerants segment, particularly for low global warming potential (GWP) refrigerants, contributing to a 22% sales increase.
- The backlog in the Alternative Energy Services (AES) segment grew 12% sequentially, indicating strong order activity.
- Focus on capital allocation towards high-return growth areas, including semiconductor materials and cooling technologies.
3. Forward Guidance and Outlook
- Full year 2025 guidance remains intact: net sales projected between $3.75 billion and $3.85 billion, with an adjusted EBITDA margin of approximately 25%.
- Anticipated EBITDA and margin decline in Q4 due to transitory costs and seasonal factors, with expectations of improved performance in 2026 as the company moves past these challenges.
4. Bad News, Challenges, or Points of Concern
- Net Loss: The reported net loss of $35 million reflects the impact of higher tax expenses due to the spin-off.
- Margin Pressure: Adjusted EBITDA margin declined year-over-year, primarily due to transitory costs and a shift in refrigerants product mix.
- Volume Declines: Lower volumes in Healthcare Packaging and Research and Performance Chemicals negatively impacted sales.
- Operational Challenges: Some unplanned downtime affected production, particularly in the Electronic and Specialty Materials segment.
5. Notable Q&A Insights
- Backlog Growth: The 12% increase in AES backlog was driven by new orders rather than pricing, with capacity expansion aligned to meet anticipated demand.
- Refrigerants Segment: Margin contraction due to the transition from HFCs to HFOs was expected, with a forecast for margin improvement as the transition stabilizes and aftermarket opportunities grow.
- 2026 Outlook: Management expressed confidence that transitory costs would diminish, allowing for a more stable growth trajectory in 2026, with no anticipated further downside in margins.
- Operational Adjustments: Planned and unplanned downtime in production facilities impacted Q3 results, but operations are now fully restored.
This earnings call reflects Solstice's transition into an independent entity, highlighting both the challenges faced during the spin-off and the strategic initiatives aimed at driving future growth.
